'Endemic' Coronavirus: Cipla Defines Sustainability Of Gains

Albuterol Generic Builds Big Rx Share In US Proventil Market

 
• By Anju Ghangurde

The potentially endemic nature of the coronavirus could buoy gains for Cipla’s COVID-19 portfolio, which now includes an antibody detection kit. The Indian firm’s albuterol generic has also chipped away at market share in the US.

Red umbrella protecting merchants immune novel coronavirus pneumonia infection
Some Gains from COVID-19 Portfolio May Be Sustainable • Source: Shutterstock

More from Strategy

More from Business